Skip to main content
. 2018 Nov 15;11:707–716. doi: 10.2147/DMSO.S173809

Table 3.

Multivariable adjusteda association of PFAS with stage of kidney function, stratified by diabetes and anemia status, OR (95% CI)

Characteristics Diabetic population Non-diabetic population
Anemia No anemia Anemia No anemia
PFHxS
<30, mL/min/1.73 m2 Ref Ref Ref Ref
30–44, mL/min/1.73 m2 1.99 (1.38–2.86) 2.15 (1.42–3.27) 1.69 (1.17–2.44) 2.71 (2.02–3.65)
45–59, mL/min/1.73 m2 3.18 (2.17–4.67) 2.66 (1.79–3.95) 1.73 (1.23–2.44) 2.66 (2.02–3.49)
60–89, mL/min/1.73 m2 2.64 (1.83–3.80) 2.89 (1.97–4.24) 1.72 (1.25–2.36) 2.63 (2.01–3.45)
≥90, mL/min/1.73 m2 3.20 (2.00–5.13) 2.55 (1.73–3.77) 1.80 (1.29–2.52) 2.37 (1.81–3.11)
PFOA
<30, mL/min/1.73 m2 Ref Ref Ref Ref
30–44, mL/min/1.73 m2 1.28 (0.99–1.65) 1.83 (1.34–2.50) 1.60 (1.24–2.06) 1.72 (1.37–2.15)
45–59, mL/min/1.73 m2 1.33 (1.04–1.70) 1.75 (1.30–2.35) 1.74 (1.37–2.21) 1.69 (1.37–2.10)
60–89, mL/min/1.73 m2 1.41 (1.11–1.80) 1.84 (1.37–2.47) 1.53 (1.22–1.91) 1.72 (1.39–2.12)
≥90, mL/min/1.73 m2 1.79 (1.33–2.42) 1.82 (1.36–2.46) 1.59 (1.26–2.02) 1.67 (1.35–2.06)
PFOS
<30, mL/min/1.73 m2 Ref Ref Ref Ref
30–44, mL/min/1.73 m2 2.20 (1.58–3.07) 1.74 (1.31–2.34) 1.98 (1.42–2.74) 2.77 (2.17–3.53)
45–59, mL/min/1.73 m2 2.47 (1.78–3.43) 2.33 (1.77–3.06) 2.08 (1.54–2.80) 2.49 (2.05–3.02)
60–89, mL/min/1.73 m2 2.27 (1.68–3.07) 2.58 (1.99–3.34) 1.82 (1.42–2.33) 2.24 (1.86–2.69)
≥90, mL/min/1.73 m2 2.83 (1.88–4.26) 2.33 (1.78–3.05) 2.09 (1.58–2.77) 1.86 (1.54–2.24)
PFNA
<30, mL/min/1.73 m2 Ref Ref Ref Ref
30–44, mL/min/1.73 m2 3.16 (1.86–5.37) 3.17 (1.74–5.80) 3.23 (1.92–5.44) 4.31 (2.87–6.49)
45–59, mL/min/1.73 m2 3.30 (1.98–5.47) 3.49 (2.00–6.11) 2.73 (1.70–4.38) 3.82 (2.66–5.50)
60–89, mL/min/1.73 m2 3.33 (2.03–5.47) 4.13 (2.40–7.13) 2.49 (1.61–3.85) 3.36 (2.35–4.81)
≥90, mL/min/1.73 m2 4.38 (2.28–8.42) 4.25 (2.44–7.43) 2.59 (1.62–4.16) 2.79 (1.95–4.00)

Notes:

a

Analyses adjusted for age, sex, BMI, HDLc, LDLc, white blood cell count, CRP, hemoglobin, and iron.

Abbreviations: BMI, body mass index; CRP, C-reactive protein; HDLc, high-density lipoprotein cholesterol; LDLc, low-density lipoprotein cholesterol; PFAS, perfluoroalkyl acids; PFHxS, perfluorohexane sulfonate; PFNA, perfluorononanoic acid; PFOA, perfluorooctanoic acid; PFOS, perfluorooctane sulfonate.